1 | 0,5 mg seasonal influenza vaccine i.m. | - | - | - | - | 1件: 51 51 |
2 | 13 valent conjugated pneumococcal vaccine | - | - | - | - | 1件: 265 265 |
3 | 13-valent pneumococcal conjugate vaccine | - | - | - | - | 2件: 46 46, 53 |
4 | 13-valent pneumococcal conjugate vaccine (13-PCV) | - | - | - | - | 1件: 13 13 |
5 | 13-valent pneumococcal conjugated vaccine (PCV13) | - | - | - | - | 1件: 96 96 |
6 | 2011-2012 seasonal flu vaccine Intramuscular | - | - | - | - | 2件: 3 3, 113 |
7 | 2011-2012 seasonal flu vaccine Subcutaneous | - | - | - | - | 2件: 3 3, 113 |
8 | 23-valent pneumococcal polysaccharide vaccine | - | - | - | - | 3件: 13 13, 46, 53 |
9 | 23-valent pneumococcal polysaccharide vaccine (23-PPV) | - | - | - | - | 1件: 13 13 |
10 | 23-valent polysaccharide pneumococcal vaccine | - | - | - | - | 1件: 96 96 |
11 | 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) | - | - | - | - | 2件: 96 96, 97 |
12 | 7-valent Pneumococcal Conjugate vaccine | - | - | - | - | 1件: 46 46 |
13 | Abatacept + Vaccines | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 |
14 | Anti-pandemic H1N1 influenza vaccine | - | - | - | - | 6件: 46 46, 49, 50, 51, 53, 107 |
15 | Bacille Calmette-Guerin vaccine | - | - | - | - | 1件: 13 13 |
16 | BCG TICE Vaccine | - | - | - | - | 1件: 299 299 |
17 | Biological/Vaccine: Allogeneic HB-adMSCs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 1件: 6 6 |
18 | Conjugated pneumococcal vaccine (Prevenar) | - | - | - | - | 1件: 65 65 |
19 | COVID-19 mRNA Vaccine (nucleoside modified) | - | - | - | - | 3件: 13 13, 46, 51 |
20 | COVID-19 mRNA vaccine (nucleoside-modified) | - | - | - | - | 4件: 13 13, 46, 51, 299 |
21 | COVID-19 mRNA vaccine Moderna (CX-024414) | - | - | - | - | 4件: 13 13, 46, 51, 299 |
22 | COVID-19 vaccine | - | - | - | - | 3件: 46 46, 49, 51 |
23 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | - | - | - | - | 1件: 299 299 |
24 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | 3件: 46 46, 51, 299 |
25 | COVID-19 Vaccine AstraZeneca | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 53 |
26 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 299 |
27 | COVID-19 Vaccine AstraZeneca suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant]) | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 53 53 |
28 | Covid-19 Vaccine Janssen | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: D12129
D12129
(Name: COVID-19 vaccine) | - | - | 2件: 53 53, 299 |
29 | COVID-19 Vaccine Janssen suspension for injection | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: D12129
D12129
(Name: COVID-19 vaccine) | - | - | 1件: 299 299 |
30 | COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant]) | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: D12129
D12129
(Name: COVID-19 vaccine) | - | - | 2件: 53 53, 299 |
31 | COVID-19 Vaccine Moderna | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
(Name: COVID-19 mRNA vaccine (nucleotide modified)) | - | - | 4件: 46 46, 51, 65, 299 |
32 | COVID-19 Vaccine Moderna dispersion for injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
(Name: COVID-19 mRNA vaccine (nucleotide modified)) | - | - | 1件: 299 299 |
33 | COVID19 vaccine | - | - | - | - | 1件: 13 13 |
34 | Epaxal Berna (virosomal hepatitis A vaccine) | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 2件: 96 96, 97 |
35 | Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed). | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
36 | Focetria (Monovalent MF59-Adjuvanted vaccine) | - | - | - | - | 3件: 46 46, 49, 271 |
37 | Group C meningococcal conjugate vaccine | - | - | - | - | 1件: 14 14 |
38 | HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Synonym: Diphtheria and Tetanus Toxoids With Pertussis Vaccine Adsorbed) | - | - | - | 2件: 13 13, 14 |
39 | Haemophilus type b vaccine (conjugated) | - | - | - | - | 1件: 14 14 |
40 | HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA) | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
41 | Hepatitis A Vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 3件: 46 46, 96, 97 |
42 | Hepatitis A vaccine ( HAVRIX or EPAXAL) | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 1件: 46 46 |
43 | Hepatitis A vaccine and tetanus vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 1件: 46 46 |
44 | Hepatitis B Vaccine | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
45 | HEPATITIS B VACCINE (RDNA) | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
46 | Herpes Zoster Subunit (HZ/su) Vaccine | - | - | - | - | 1件: 49 49 |
47 | Herpes Zoster Vaccine | - | - | - | - | 3件: 46 46, 96, 271 |
48 | HPV prophylactic vaccine Gardasil | 1件: Human papillomavirus type 6 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 |
49 | Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus | - | - | - | - | 1件: 53 53 |
50 | Inactivated Trivalent Influenza vaccine | - | - | - | - | 1件: 63 63 |
51 | Influenza vaccine | - | - | - | - | 5件: 11 11, 13, 46, 51, 84 |
52 | INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED) | - | - | - | - | 1件: 49 49 |
53 | Influenza vaccine, Immune function | - | - | - | - | 1件: 107 107 |
54 | Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) | - | - | - | - | 1件: 13 13 |
55 | Moderna COVID-19 Vaccine | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
(Name: COVID-19 mRNA vaccine (nucleotide modified)) | - | - | 1件: 46 46 |
56 | Most recent vaccine to seasonal influenza | - | - | - | - | 1件: 13 13 |
57 | MRNA COVD19 vaccine | - | - | - | - | 3件: 49 49, 53, 271 |
58 | Pertussis vaccine | 1件: Pertussis vaccine Pertussis vaccine | 1件: D06514
D06514
(Name: Pertussis vaccine) | - | - | 2件: 13 13, 46 |
59 | Pneumococcal conjugate vaccine | - | - | - | - | 1件: 46 46 |
60 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) | - | - | - | - | 2件: 13 13, 14 |
61 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE | 4件: Aluminium Aluminium, Aluminium phosphate, Corynebacterium diphtheriae CRM197 protein, Phosphate ion | - | - | - | 1件: 46 46 |
62 | Pneumococcal polysaccharide vaccine | - | - | - | - | 3件: 13 13, 46, 222 |
63 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) | - | - | - | - | 1件: 46 46 |
64 | Pneumococcal polysaccharide vaccine 23 valent | - | - | - | - | 1件: 265 265 |
65 | Pneumococcal polysaccharide vaccine solution for injection in a vial | - | - | - | - | 1件: 222 222 |
66 | Pneumovax® (pneumococcal polysaccharide vaccine) | - | - | - | - | 1件: 65 65 |
67 | Prevenar vaccine | - | - | - | - | 1件: 46 46 |
68 | Prevenar® (7-valent pneumococcal conjugate vaccine) | - | - | - | - | 1件: 65 65 |
69 | Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal) | - | - | - | - | 1件: 13 13 |
70 | Purified Vero Cell Vaccine) | - | - | - | - | 1件: 65 65 |
71 | Quadrivalent HPV vaccine | - | - | - | - | 1件: 107 107 |
72 | Quadrivalent influenza vaccine | - | - | - | - | 1件: 13 13 |
73 | Recombinant zoster vaccine | - | - | - | - | 2件: 13 13, 49 |
74 | SARS-COV-2 mRNA Vaccine | 1件: CVnCoV CVnCoV (Synonym: SARS-CoV-2 mRNA vaccine) | - | - | - | 1件: 13 13 |
75 | Seasonal influenza vaccine | - | - | - | - | 2件: 13 13, 46 |
76 | Seasonal influenza vaccine available for the 2012-2013 vaccine campaign | - | - | - | - | 1件: 84 84 |
77 | Seasonal Quadrivalent influenza vaccine | - | - | - | - | 1件: 13 13 |
78 | TBE-vaccine | - | - | - | - | 1件: 46 46 |
79 | Tetanus + pnemococcal vaccines alone | - | - | - | - | 1件: 46 46 |
80 | Tetanus diphtheria toxoid vaccine (Td) | 1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (Synonym: Prohibit Inj Vaccine) | - | - | - | 1件: 13 13 |
81 | Tetanus diphtheria toxoids vaccine | - | - | - | - | 1件: 13 13 |
82 | Tetanus toxoid (TT) containing vaccine (Td, Tdap) | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Synonym: Diphtheria and Tetanus Toxoids With Pertussis Vaccine Adsorbed) | - | - | - | 1件: 13 13 |
83 | Tetanus toxoid adsorbed booster vaccine | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Synonym: Diphtheria and Tetanus Toxoids With Pertussis Vaccine Adsorbed) | - | - | - | 1件: 46 46 |
84 | Tetanus Toxoid Adsorbed Vaccine | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Synonym: Diphtheria and Tetanus Toxoids With Pertussis Vaccine Adsorbed) | - | - | - | 1件: 46 46 |
85 | Tetanus toxoid vaccine | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Synonym: Diphtheria and Tetanus Toxoids With Pertussis Vaccine Adsorbed) | - | - | - | 1件: 13 13 |
86 | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) | 3件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Synonym: Diphtheria and Tetanus Toxoids With Pertussis Vaccine Adsorbed), Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (Synonym: Prohibit Inj Vaccine), Pertussis vaccine | 1件: D06514
D06514
(Name: Pertussis vaccine) | - | - | 1件: 46 46 |
87 | Tetanus, diphtheria, and acellular pertussis vaccine | 1件: Pertussis vaccine Pertussis vaccine | 1件: D06514
D06514
(Name: Pertussis vaccine) | - | - | 1件: 13 13 |
88 | The 0.5 mL dose of vaccine contains 25 micrograms of each of the following 23 pneumococcal polysaccharide | - | - | - | - | 1件: 222 222 |
89 | Tovaxin Autologous T Cell Vaccine | - | - | - | - | 1件: 13 13 |
90 | Tozinameran (Synonym: COVID-19 mRNA vaccine (nucleoside-modified)) | 1件: Tozinameran Tozinameran (Synonym: Pfizer-BioNTech Covid-19 Vaccine) | 1件: D11971
D11971
(Name: COVID-19 mRNA vaccine (nucleoside-modified)) | - | - | 1件: 299 299 |
91 | Trivalent inactivated influenza vaccine | - | - | - | - | 1件: 46 46 |
92 | Trivalent seasonal influenza vaccine | - | - | - | - | 1件: 13 13 |
93 | TT Vaccine | - | - | - | - | 1件: 13 13 |
94 | Vaccination with vaccine against hepatitis A and B | - | - | - | - | 1件: 299 299 |
95 | Vaccine | - | - | - | - | 1件: 49 49 |
96 | Vaccine Vivotif + Vaccine Dukoral | 2件: Recombinant Cholera Toxin B Subunit Recombinant Cholera Toxin B Subunit, Typhoid Vaccine Live | - | - | - | 1件: 97 97 |
97 | Vaccine Vivotif + Vaccine Dukoral + oats | 3件: Oat Oat, Recombinant Cholera Toxin B Subunit, Typhoid Vaccine Live | - | - | - | 1件: 97 97 |
98 | Varicella Zoster Vaccine | - | - | - | - | 1件: 46 46 |
99 | Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 299 299 |
100 | Yellow fever vaccine | 1件: Yellow fever vaccine Yellow fever vaccine | 1件: D06347
D06347
(Name: Yellow fever vaccine) | - | - | 8件: 40 40, 44, 46, 50, 51, 52, 53, 107 |
101 | Yellow Fever vaccine (17D) | 1件: Yellow fever vaccine Yellow fever vaccine | 1件: D06347
D06347
(Name: Yellow fever vaccine) | - | - | 8件: 40 40, 44, 46, 50, 51, 52, 53, 107 |
102 | Zostavax (varicella zoster virus) vaccine | 1件: Varicella zoster vaccine (live/attenuated) Varicella zoster vaccine (live/attenuated) | - | - | - | 1件: 46 46 |
103 | Zostavax vaccine | 1件: Varicella zoster vaccine (live/attenuated) Varicella zoster vaccine (live/attenuated) | - | - | - | 2件: 46 46, 49 |